The present invention relates to compositions comprising (i) an activator of transport of fatty acids into the mitochondria (ii) an activator of fatty acid oxidation and (iii) an inhibitor of fatty acid biosynthesis, and methods for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome, dyslipidemias, obesity, and/or cardiovascular disorders in a subject.
